Until recently, IL-11 was better known for its capacity to stimulate platelet production, and for decades, cancer patients have been treated with rhIL-11 to overcome CT-induced thrombocytopenia (Isaacs et al., 1997; Cairo et al., 2005; Wu et al., 2012). This evidence concerns the gene IL11 and Thrombocytopenia.